There are several studies revealing that NF-kB is a critical mediator of the pathogenesis of intestinal inflammation, and therefore, it is suggested as an attractive therapeutic target for the treatment of various intestinal inflammatory disorders in humans12. This evidence concerns the gene NFKB1 and inflammation.